What over‑the‑counter (OTC) medications are recommended for treating solar lentigines (age spots)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

OTC Medications for Age Spots (Solar Lentigines)

For over-the-counter treatment of solar lentigines (age spots), topical retinoids (adapalene 0.1% gel) combined with azelaic acid 20% represent the most evidence-based OTC approach, though efficacy remains modest compared to prescription options or procedural treatments.

Primary OTC Recommendations

Adapalene 0.1% Gel (Available OTC)

  • Mechanism: Comedolytic, anti-inflammatory, and addresses precursor lesions 1
  • Application: Evening application, can be combined with other agents
  • Evidence: While primarily studied for acne, retinoids are effective for dyspigmentation and photoaging 1, 2
  • Tolerability: May cause initial irritation, dryness, and photosensitivity; start with reduced frequency and use concurrent emollients 3
  • Sun protection: Mandatory daily sunscreen use due to photosensitivity risk 3

Azelaic Acid 20%

  • Mechanism: Mildly comedolytic, antibacterial, and anti-inflammatory with specific lightening effects on dyspigmentation 1
  • Evidence: Particularly useful for Fitzpatrick skin types IV or greater due to lightening effect on hyperpigmentation 1
  • Application: Can be used in combination with retinoids
  • Safety: Pregnancy category B 1
  • Efficacy limitation: One study showed azelaic acid 20% was ineffective on established solar lentigines 4, suggesting it may work better for prevention or early lesions

Salicylic Acid (0.5-2%)

  • Availability: Over-the-counter in various formulations 1
  • Evidence: Limited clinical trial data specifically for solar lentigines 1
  • Role: Mild comedolytic agent; may provide modest benefit as adjunctive therapy

Important Clinical Caveats

Realistic Expectations

The evidence shows OTC topical agents have limited efficacy for established solar lentigines. Research demonstrates:

  • Azelaic acid 20% showed no significant effect on established solar lentigines 4
  • Topical retinoids (adapalene 0.3%) showed modest benefit after 9 months for actinic keratoses, a related condition 2
  • Subclinical or faint mottled pigmentation responds better than established lesions 4

When OTC Treatment is Insufficient

Individual lesions that fail to respond to topical therapy require further evaluation, potentially including:

  • Referral to dermatology for assessment
  • Consideration of procedural treatments (lasers, cryotherapy, chemical peels) 2, 5, 6
  • Histological evaluation if there's concern about the diagnosis

Prescription Alternatives (Not OTC)

For context, prescription options show superior efficacy:

  • Mequinol 2% + tretinoin 0.01%: 52.6-80% efficacy for facial lesions 5
  • Stabilized cysteamine: 40% reduction in colorimetric values 7
  • Hydroquinone: Effective but not approved for OTC use in the US 8

Practical Treatment Algorithm

  1. Start with combination therapy:

    • Adapalene 0.1% gel (evening application)
    • Azelaic acid 20% (can apply morning or as tolerated)
    • Daily broad-spectrum sunscreen (mandatory)
  2. Manage tolerability:

    • Begin with every-other-night application of adapalene
    • Use concurrent emollients to reduce irritation 3
    • Gradually increase frequency as tolerated
  3. Timeline for assessment:

    • Evaluate response at 3-4 months minimum
    • Full effect may require 6-9 months 2
  4. If inadequate response after 3-4 months:

    • Consider referral for prescription topicals (mequinol/tretinoin combination)
    • Discuss procedural options (lasers show 67.9-93% success rates) 5

Critical Warnings

  • Sun protection is non-negotiable: UV exposure causes and worsens solar lentigines; treatment without sun protection is futile
  • Retinoids increase photosensitivity: Daily sunscreen is mandatory 3
  • Avoid benzoyl peroxide with tretinoin: Causes oxidation and inactivation (though adapalene lacks this restriction) 3
  • Lesions requiring biopsy: Any atypical, rapidly changing, or treatment-resistant lesions warrant dermatologic evaluation 2

Bottom line: OTC options for solar lentigines provide modest benefit at best, primarily working through photoaging reversal rather than direct depigmentation. Most patients with cosmetically significant solar lentigines will ultimately require prescription topicals or procedural interventions for satisfactory results 5, 6.

References

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Research

Treatment of Lentigines: A Systematic Review.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2023

Related Questions

What treatments effectively remove benign solar lentigines (age spots) in adults?
Can you provide a treatment algorithm, preferably in diagram form, for managing solar lentigo and melasma?
What is the most effective laser for treating solar lentigines (sun spots)?
Is there an over‑the‑counter product comparable to the prescription mequinol 2 %/tretinoin 0.01 % combination for treating age‑related sunspots in a non‑pregnant patient without allergies?
What are the topical treatment options for solar lentigines (lentigines solares, also known as age spots or liver spots)?
Are methyl salicylate patches effective for relieving superficial musculoskeletal pain?
What is the role of gamma-aminobutyric acid (GABA) in opioid withdrawal?
What is the recommended approach to managing chronic kidney disease in primary care?
What is the recommended treatment for a patient with complicated oral or esophageal thrush and a concurrent complicated genital yeast infection?
Should a 32-year-old postpartum woman with type 2 diabetes, weight 65 kg, creatinine 0.63 mg/dL, estimated glomerular filtration rate >90 mL/min/1.73 m², hemoglobin A1c 5.6%, previously insulin‑dependent but not on insulin during pregnancy, currently taking clonidine, hydroxyzine (Atarax), magnesium, methadone, cyclobenzaprine (Robaxin), misoprostol, and oxytocin, with blood glucose readings of 153 mg/dL at 2 am, 257 mg/dL at 7 am, and 197 mg/dL at noon, and using an insulin sensitivity factor of 50 for correction, should she be started on any diabetes medication at discharge?
Can a patient take lithium and Depakote (valproic acid) together?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.